EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study

Nobuhiro Ueno iD, Yuya Sugiyama, Yu Kobayashi, Yuki Murakami, Takuya Iwama, Takahiro Sasaki, Takehito Kunogi, Aki Sakatani, Keitaro Takahashi, Kazuyuki Tanaka, Shinya Serikawa, Katsuyoshi Ando und 7 weitere

Journal of Clinical Apheresis · 2023

DOI: 10.1002/jca.22040 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Clinical Apheresis, 2023. Verfasst von Nobuhiro Ueno und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolism and Biosystemic Science, Gastroenterology, and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asah…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Blood Component Removal, Biological Products. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Granulocyte and monocyte adsorptive apheresis (GMA) with Adacolumn has been used as a remission induction therapy for patients with active ulcerative colitis (UC). Herein, we investigated the influence of concomitant medications in the remission induction of GMA in patients with active UC.

Methods

This multicenter retrospective cohort study included patients with UC underwent GMA in five independent institutions in Japan from January 2011 to July 2021. Factors including concomitant medications associated with clinical remission (CR) were analyzed statistically.

Result

A total of 133 patients were included. Seventy‐four patients achieved a CR after GMA. The multivariable analysis revealed that concomitant medication with 5‐aminosalicylic acid, Mayo endoscopic subscore (MES), and concomitant medication with immunosuppressors (IMs) remained as predictors of CR after GMA. In the subgroup analysis in patients with MES of 2, concomitant medication with IMs was demonstrated as a significant negative factor of CR after GMA ( P = .042, OR 0.354). Seventy‐four patients who achieved CR after GMA were followed up for 52 weeks. In the multivariable analysis, the maintenance therapy with IMs was demonstrated as a significant positive factor of sustained CR up to 52 weeks ( P = .038, OR 2.214). Furthermore, the rate of sustained CR in patients with biologics and IMs was significantly higher than that in patients with biologics only ( P = .002).

Conclusion

GMA was more effective for patients with active UC that relapsed under treatment without IMs. Furthermore, the addition of IMs should be considered in patients on maintenance therapy with biologics after GMA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeBlood Component RemovalBiological ProductsHumansMonocytesRetrospective StudiesTreatment OutcomeGranulocytesRemission InductionLeukapheresis

Stichwörter der Autor:innen

biologicsclinical remissiongranulocyte and monocyte apheresisimmunosuppressorsloss of responsenegative factorpositive factorulcerative colitis

Substanzen

Biological Products

Autor:innen und Institutionen

  • Division of Metabolism and Biosystemic Science, Gastroenterology, and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
  • Asahikawa City Hospital, Asahikawa, Hokkaido, Japan.
  • Asahikawa Kosei General Hospital, Asahikawa, Hokkaido, Japan.
  • Nayoro City General Hospital, Nayoro, Hokkaido, Japan.
  • Engaru Kosei General Hospital, Hokkaido, Japan.

ORCID-Profile: Nobuhiro Ueno

Zitieren

APA

Ueno, N., Sugiyama, Y., Kobayashi, Y., Murakami, Y., Iwama, T., Sasaki, T., Kunogi, T., Sakatani, A., Takahashi, K., Tanaka, K., Serikawa, S., Ando, K., Kashima, S., Muto, M., Inaba, Y., Moriichi, K., Tanabe, H., Okumura, T., & Fujiya, M. (2023). Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.22040

Vancouver

Ueno N, Sugiyama Y, Kobayashi Y, Murakami Y, Iwama T, Sasaki T, et al. Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study. Journal of Clinical Apheresis. 2023. doi:10.1002/jca.22040

BibTeX
@article{Ueno2023,
  author = {Ueno, Nobuhiro and Sugiyama, Yuya and Kobayashi, Yu and Murakami, Yuki and Iwama, Takuya and Sasaki, Takahiro and Kunogi, Takehito and Sakatani, Aki and Takahashi, Keitaro and Tanaka, Kazuyuki and Serikawa, Shinya and Ando, Katsuyoshi and Kashima, Shin and Muto, Momotaro and Inaba, Yuhei and Moriichi, Kentaro and Tanabe, Hiroki and Okumura, Toshikatsu and Fujiya, Mikihiro},
  title = {Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study},
  journal = {Journal of Clinical Apheresis},
  year = {2023},
  doi = {10.1002/jca.22040}
}
Kostenlos starten →